More stories

  • in

    As Trump Says He’s Stamping Out Antisemitism, He Advances Similar Tropes

    President Trump’s effort to punish Harvard over antisemitism is complicated by his own extensive history of amplifying white supremacist figures and symbols.In the Oval Office one day last week, President Trump renewed his no-holds-barred attack on the nation’s oldest university. “They’re totally antisemitic at Harvard,” he declared.Just 10 hours later, he posted an image of himself striding down a street with the caption, “He’s on a mission from God and nothing can stop what is coming.” Shown in the shadows, watching with approval, was a cartoon figure commonly seen as an antisemitic symbol.The appearance of the figure, the alt-right mascot Pepe the Frog, was the latest example of Mr. Trump’s extensive history of amplifying white supremacist figures and symbols, even as he now presents himself as a champion for Jewish students oppressed by what he says is a wave of hatred on American college campuses.As a younger man, Mr. Trump kept a book of Adolf Hitler’s speeches in a cabinet by his bed, according to his first wife. During his first term as president, he expressed admiration for some aspects of the Nazi Führer’s leadership, according to his chief White House aide at the time. In the past few years, he has dined at his Florida estate with a Holocaust denier while his New Jersey golf club has hosted events at which a Nazi sympathizer spoke.Since reclaiming the White House, Mr. Trump has brought into his orbit and his administration people with records of advancing antisemitic tropes, including a spokeswoman at the Pentagon. His vice president, secretary of state and top financial backer have offered support to a far-right German political party that has played down atrocities committed by the Nazis. And just last week, Mr. Trump picked a former right-wing podcaster who has defended a prominent white supremacist to head the Office of Special Counsel.Even some prominent critics of Harvard’s handling of antisemitism on its campus find Mr. Trump to be an unpalatable and unconvincing ally. In their view, his real motivations in using the power of the federal government to crush Harvard, seen by the political right as a bastion of America’s liberal, multicultural order, have little to do with concern about a hostile environment for Jewish students.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Newark’s Mayor Sues a Top Trump Lawyer, Claiming Malicious Prosecution

    The mayor, Ras Baraka, is suing Alina Habba, the interim U.S. attorney for New Jersey, who dropped charges against him soon after his arrest near an immigration jail.Mayor Ras J. Baraka of Newark, a Democratic candidate for governor who was arrested last month outside an immigration detention center, filed a federal lawsuit on Tuesday against Alina Habba, the interim U.S. attorney for New Jersey, that argues that his arrest was motivated by political malice, not justice.The lawsuit also names Ricky Patel, a supervising agent with Homeland Security Investigations who led the arrest of Mr. Baraka on May 9 outside a 1,000-bed detention center near Newark Liberty International Airport that has become a flashpoint in President Trump’s immigration crackdown.Mr. Baraka’s lawsuit accuses the federal authorities of false arrest and malicious prosecution. It also accuses Ms. Habba of defamation.The suit comes as polling locations opened Tuesday for six days of early voting ahead of a June 10 primary that has pitted Mr. Baraka against five other Democrats.Last month, Ms. Habba, who was appointed by Mr. Trump to be the state’s top federal prosecutor, abruptly announced that she was dropping a trespassing charge against Mr. Baraka — a development that prompted a federal judge to publicly question the validity of the “hasty arrest” in the first place.“Your role is not to secure convictions at all costs, nor to satisfy public clamor, nor to advance political agendas,” the judge, André M. Espinosa, said in a rare and harshly worded rebuke of the U.S. attorney’s office that Ms. Habba leads and where he once worked as a prosecutor.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Is Peeing ‘Just in Case’ Bad for Your Bladder Health?

    Q: A urologist recently told me I shouldn’t go to the bathroom “just in case.” Is that true?As children, many of us were encouraged to pee before we left the house or whenever a bathroom was nearby. There was a good reason: using the bathroom “just in case” can help prevent accidents among children prone to “holding it.”Urologists call this practice “convenience” or “proactive” voiding, and people of all ages do it, often before heading out the door or going to sleep.An occasional “just in case” bathroom break won’t do much harm, said Dr. Ariana Smith, a professor of urology at the University of Pennsylvania Perelman School of Medicine. But doing it several times a day, she said, can increase the likelihood of bladder issues by disrupting the natural feedback loop between your bladder and your brain.How does peeing ‘just in case’ affect bladder health?To understand why proactive voiding can be harmful, it helps to know how the bladder works. As your kidneys filter blood to remove waste, they produce urine, which is carried to your bladder. Women can typically hold up to 500 milliliters of urine, or around two cups, in their bladders; men can store 700 milliliters, or nearly three cups.We generally feel the urge to use the bathroom well before we hit that limit, when our bladder contains between 150 and 250 milliliters of liquid. As the bladder fills up, it sends nerve signals to the brain, letting us know it’s time to go.The experts we spoke with said that when you pee “just in case,” your bladder starts alerting your brain too early, before having the standard amount of urine. This disruption can reduce “the volume your bladder can hold over time,” said Siobhan Sutcliffe, an epidemiologist and professor of surgery at Washington University.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    At the Tribeca Festival, Standouts Come From Near and Far

    A documentary about a New York restaurant and a Korean film about dine-and-dashers are among the standouts in this year’s festival.“You have to be used to change in New York,” Matthew Broderick remarks in “Raoul’s, a New York Story,” a documentary highlight of this year’s Tribeca Festival. The film centers on the celebrated French bistro, which opened in Soho in 1975 amid a cultural renaissance and became a fixture for local artists. Since then, survival of the richest has all but erased la vie bohème from the neighborhood in favor of a catwalk of retail storefronts — though Raoul’s is still standing, its arty interior nearly unmodified.To Broderick, that’s just life in the city. “Everything we hold incredibly dear,” he says in an interview in the film, “took over for something that somebody else held dear.”His remarks could very well be a slogan for the Tribeca Festival. Its obsession with novelty has, in recent years, made it an almost manically multifarious affair. Alongside movies, this year’s edition — which runs Wednesday through June 15 — will host video games, audio storytelling and an immersive program stamped with a catalog of acronyms: A.R., V.R., A.I. While festivals like Cannes are steeped in tradition, Tribeca is eager to be seen as a celebration of transformation, a festival of the future.The zeal with which Tribeca pushes forward can feel exciting, but like an overactive online shopper, it also generates clutter. It’s hard to find the gems. Sampling this year’s lineup, I found that the most memorable world premieres sorted into two subsets: the near and the far. International standouts come from Korea, India and Chile — a long way from the Triangle Below Canal Street. Then there are the local discoveries, capturing a New York spirit that aligns with the festival’s setting.Straddling both categories is “Raoul’s,” which tells the story of the Soho canteen by tracing its origins to Alsace, France, and then chronicling the Raoul men’s travels in Bali, Indonesia. The documentary was shot over a decade by Greg Olliver alongside Karim Raoul, who took over the restaurant’s day-to-day operations after his father, the founder Serge Raoul, suffered a stroke. As such, the film is as much a portrait of a local institution as it is a tale of a father and a son, exploring notions of legacy, heritage and what it means to sideline personal dreams for family obligations.A scene from Yang Jong-hyun’s film “People and Meat.”via Tribeca FestivalWe are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    What to Know About China’s Halt of Rare Earth Exports

    Since early April, China has stopped almost all shipments of critical minerals that are needed for cars, robots, wind turbines, jet fighters and other technologies.China has suspended almost all exports since April 4 of seven kinds of rare earth metals, as well as very powerful magnets made from three of them. The halt has caused increasingly severe shortages that threaten to close many factories in the United States and Europe.Why are these metals so needed, why has China stopped exporting them and, crucially, what happens next?What are rare earths?There are 17 types of metals known as rare earths, which are found near the bottom of the periodic table. Most of them are not actually very rare — they are all over the world, though seldom in large enough ore deposits to be mined efficiently.They are called rare because it is very difficult to separate them from each other. Breaking the chemical bonds that bind them in nature can require more than 100 stages of processing and large quantities of powerful acids.A close-up of a gram of terbium.Romain Rabier/Hans Lucas, via ReutersWhy does China control so much of the rare earth supply?China mines 70 percent of the world’s rare earths. Myanmar, Australia and the United States mine most of the rest. But China does the chemical processing for 90 percent of the world’s rare earths because it refines all of its own ore and also practically all of Myanmar’s and nearly half of U.S. production.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Trump’s Deportation Flights Increased in May, Data Shows

    <!–> –><!–> [–><!–> –><!–> [–><!–> –><!–> [–><!–> –><!–> [–><!–>Immigration arrests spiked immediately after Mr. Trump took office, but deportations had remained relatively flat because of a drop in the number of people apprehended at the border.–><!–> –><!–> [–><!–>The Trump administration has rolled back Biden-era protections for many migrants, expanding who has been targeted for deportation. […] More

  • in

    Tesla Protesters Claim a Victory as Elon Musk Leaves Trump’s Side

    The activists behind the Tesla Takedown campaign say they intend to expand beyond protests at the company’s showrooms.Elon Musk left the Trump administration with a White House send-off on Friday. That was a victory of sorts for a group of activists who have spent much of the last four months organizing protests against Mr. Musk’s right-wing politics by targeting his electric car company, Tesla.A day later, on Saturday, hundreds of people showed up at more than 50 Tesla showrooms and other company locations to continue their protests.The campaign at Tesla sites began in February after Joan Donovan, a sociology professor at Boston University, gathered friends to hold a demonstration at a Tesla showroom in Boston, and posted a notice about her plan on Bluesky using the hashtag #TeslaTakedown. She said she had been inspired by a small protest at Tesla’s electric vehicle chargers in Maine soon after President Trump’s inauguration.“That first one on Feb. 15 was me and like 50 people,” Ms. Donovan said. “And then the next week it was a hundred more people, and then a hundred more after that, and it’s just grown.”Tesla Takedown has since expanded into an international movement, staging demonstrations at Tesla factories, showrooms and other locations in countries including Australia, Britain, France and Germany as well as across the United States. The campaign’s U.S. growth has been fueled in large part by anger over Mr. Musk’s leadership of the Department of Government Efficiency, which has slashed government spending and dismissed tens of thousands of federal workers while gaining access to sensitive personal data.Mr. Musk departed the administration after his involvement in politics hurt his companies, especially Tesla. Sales of the company’s cars have tumbled since Mr. Trump took office and the start of protests against the company.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    From No Hope to a Potential Cure for a Deadly Blood Cancer

    Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death.A group of 97 patients had longstanding multiple myeloma, a common blood cancer that doctors consider incurable, and faced a certain, and extremely painful, death within about a year. They had gone through a series of treatments, each of which controlled their disease for a while. But then it came back, as it always does. They reached the stage where they had no more options and were facing hospice.They all got immunotherapy, in a study that was a last-ditch effort.A third responded so well that they got what seems to be an astonishing reprieve. The immunotherapy developed by Legend Biotech, a company founded in China, seems to have made their cancer disappear. And after five years, it still has not returned in those patients — a result never before seen in this disease.These results, in patients whose situation had seemed hopeless, has led some battle-worn American oncologists to dare to say the words “potential cure.”“In my 30 years in oncology, we haven’t talked about curing myeloma,” said Dr. Norman Sharpless, a former director of the National Cancer Institute who is now a professor of cancer policy and innovation at the University of North Carolina School of Medicine. “This is the first time we are really talking seriously about cure in one of the worst malignancies imaginable.”The new study, reported Tuesday at the annual conference of the American Society of Clinical Oncology and published in The Journal of Clinical Oncology, was funded by Johnson & Johnson, which bought Legend Biotech.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More